NIIMBL Aims To Help Manufacturers Perfect Next-Generation COVID-19 Vaccines
Public-private partnership could help coronavirus vaccine developers increase thermal stability, strengthen potency assays and fine-tune adventitious agent testing, among other things.
You may also be interested in...
Demand surges, supply surges and investigator travel restrictions are forcing FDA to adopt less restrictive regulatory approaches during the pandemic.
Agency may share outcomes of remote record reviews in lieu of inspections at US and foreign facilities.
Emerging global standard could speed testing of biologics and gene therapies for stray viral particles, while sparing laboratory animals.